Blood glucose level and insulin resistance in patients with type 2 diabetic mellitus, diabetic retinopathy and obesity

Main Article Content

N.V. Malachkova
I.V. Komarovskaya
M.L. Kyryliuk


Background. Diabetic retinopathy is the main cause of visual disorders in the world. The purpose of our work was to study the level of glycaemia and insulin resistance in patients with type 2 diabetes mellitus (DM), diabetic retinopathy and obesity. Materials and methods. One-hundred and seven diabetic patients (234 eyes) observed were divided in two groups. Results. The levels of blood glucose and insulin resistance were studied at different stages of diabetic retinopathy (DR) in patients with type 2 DM. Using ANOVA it was shown that all patients with DR, regardless of study group, had chronic hyperglycemia with decompensated T2DM. The carbohydrate metabolism was found to begin impro­ving only at the 3rd stage of DR, however it occurs on a background of hypoglycemia. Conclusions. The greatest proportion of patients with adverse indices of insulin resistance by HOMA-IR index (87.5 ± 11.6%) and with reduced sensitivity to insulin by QUICKI index (62.5 ± 17.1 %) had proliferative DR stage compared to the comparative and control groups (obese patients without T2DM): 55.0 ± 11.1%; p < 0.001, and 25.0 ± 9.68 %; p < 0.001, respectively.

Article Details

How to Cite
Malachkova, N., I. Komarovskaya, and M. Kyryliuk. “Blood Glucose Level and Insulin Resistance in Patients With Type 2 diabetic Mellitus, Diabetic Retinopathy and Obesity”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 13, no. 3, June 2017, pp. 129-34, doi:10.22141/2224-0721.13.3.2017.104108.
Original Researches


Kirilyuk M. Drug treatment of diabetic retinopathy in type 1 diabetes: review of the literature and clinical trials. Mezhdunarodnyi Endokrinologicheskii Zhurnal. 2012;5(45):70-75. (In Ukrainian).

Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond). 2015 Sep 30;2:17. doi: 10.1186/s40662-015-0026-2.

Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;1(38):140-9. doi: 10.2337/dc14-2441.

International Diabetes Federation. Managing older people with Type 2 Diabetes. Global Guideline, 2013. Available from:

Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985;28(7):412-9. PMID: 3899825.

Wallace TM, Levy JC, Matthews DR. Use and Abuse of HOMA Modeling. Diabetes Care. 2004;27(6):1487-1495. PMID:15161807.

Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85(7):2402-10. doi: 10.1210/jcem.85.7.6661.

Most read articles by the same author(s)